Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'EPITHELIAL OVARIAN-CANCER' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 417 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Fitzpatrick, FA
      Inflammation, carcinogenesis and cancer

      INTERNATIONAL IMMUNOPHARMACOLOGY
    2. Gately, S; Kerbel, R
      Antiangiogenic scheduling of lower dose cancer chemotherapy

      CANCER JOURNAL
    3. Howell, SB
      Clinical applications of a novel sustained-release injectable drug delivery system: DepoFoam (TM) technology

      CANCER JOURNAL
    4. Murphy, PA
      Putting risk in perspective: An evidence-based approach to selected risks associated with the use of oral contraception

      JOURNAL OF MIDWIFERY & WOMENS HEALTH
    5. Morris, SM; Cooper, JA
      Disabled-2 colocalizes with the LDLR in clathrin-coated pits and interactswith AP-2

      TRAFFIC
    6. Paavonen, J
      Chlamydia trachomatis and cancer

      SEXUALLY TRANSMITTED INFECTIONS
    7. Zumkeller, W
      IGFs and IGFBPs: surrogate markers for diagnosis and surveillance of tumour growth?

      JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY
    8. Campbell, IG; Thomas, EJ
      Endometriosis: candidate genes

      HUMAN REPRODUCTION UPDATE
    9. Limonta, P; Marelli, MM; Moretti, RM
      LHRH analogues as anticancer agents: pituitary and extrapituitary sites ofaction

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    10. Naidu, R; Wahab, NA; Yadav, M; Kutty, MK; Nair, S
      Detection of amplified int-2/FGF-3 gene in primary breast carcinomas usingdifferential polymerase chain reaction

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    11. Noujaim, AA; Schultes, BC; Baum, RP; Madiyalakan, R
      Induction of CA125-specific B and T cell responses in patients injected with MAb-B43.13 - Evidence for antibody-mediated antigen-processing and presentation of CA125 in vivo

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    12. McCarter, MD; Fong, YM
      Role for surgical cytoreduction in multimodality treatments for cancer

      ANNALS OF SURGICAL ONCOLOGY
    13. Baron, AT; Lafkyk, JM; Suman, VJ; Hillman, DW; Buenafe, MC; Boardman, CH; Podratz, KC; Perez, EA; Maihle, NJ
      A preliminary study of serum concentrations of soluble epidermal growth factor receptor (sErbB1), gonadotropins, and steroid hormones in healthy men and women

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    14. Kaufman, DW; Rosenberg, L; Mitchell, AA
      Signal generation and clarification: use of case-control data

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    15. Tamussino, KF; Gucer, F; Reich, O; Moser, F; Petru, E; Scholz, HS
      Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    16. Howells, REJ; Holland, T; Dhar, KK; Redman, CWE; Hand, P; Hoban, PR; Jones, PW; Fryer, AA; Strange, RC
      Glutathione S-transferase GSTIM1 and GSTT1 genotypes in ovarian cancer: association with p53 expression and survival

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    17. Mahavni, V; Sood, AK
      Hormone replacement therapy and cancer risk

      CURRENT OPINION IN ONCOLOGY
    18. Matsumoto, Y; Ishiko, O; Nakagawa, E; Sumi, T; Hyun, Y; Ando, Y; Ogita, S
      Pharmacokinetics and pharmacodynamics of serum platinum of gynecologic cancer patients treated with nedaplatin

      ONCOLOGY REPORTS
    19. Tsai, MH; Chiou, SH; Chow, KC
      Effect of platelet activating factor and butyrate on the expression of interleukin-2 receptor alpha in nasopharyngeal carcinoma cells

      INTERNATIONAL JOURNAL OF ONCOLOGY
    20. de Poncheville, L; Perrotin, F; Lefrancq, T; Lansac, J; Body, G
      Does paraaortic lymphadenectomy have a benefit in the treatment of ovariancancer that is apparently confined to the ovaries?

      EUROPEAN JOURNAL OF CANCER
    21. Underhill, CR; Parnis, FX; Highley, MS; Ahern, J; Harper, PG; Hansen, H; Lund, B; Dombernowsky, P; Hirsch, F; Hansen, M; Carmichael, J; Williams, C
      Multicenter phase II study of gemcitabine in previously untreated patientswith advanced epithelial ovarian cancer

      ANTI-CANCER DRUGS
    22. Wang, SC; Makino, K; Xia, WY; Kim, JS; Im, SA; Peng, H; Mok, SC; Singletary, SE; Hung, MC
      DOC-2/hDab-2 inhibits ILK activity and induces anoikis in breast cancer cells through an Akt-independent pathway

      ONCOGENE
    23. Tonin, PN; Hudson, TJ; Rodier, F; Bossolasco, M; Lee, PD; Novak, J; Manderson, EN; Provencher, D; Mes-Masson, AM
      Microarray analysis of gene expression mirrors the biology of an ovarian cancer model

      ONCOGENE
    24. Ruka, W; Rutkowski, P; Kaminska, J; Rysinska, A; Steffen, J
      Alterations of routine blood tests in adult patients with soft tissue sarcomas: Relationships to cytokine serum levels and prognostic significance

      ANNALS OF ONCOLOGY
    25. Scholl, S; Beuzeboc, P; Pouillart, P
      Targeting HER2 in other tumor types

      ANNALS OF ONCOLOGY
    26. Le Pendu, J; Marionneau, S; Cailleau-Thomas, A; Rocher, J; Le Moullac-Vaidye, B; Clement, M
      ABH and Lewis histo-blood group antigens in cancer

      APMIS
    27. Newman, L; Xia, WY; Yang, HY; Sahin, A; Bondy, M; Lukmanji, F; Hung, MC; Lee, MH
      Correlation of p27 protein expression with HER-2/neu expression in breast cancer

      MOLECULAR CARCINOGENESIS
    28. Horowitz, NS; Rader, JS
      Role of the ultrasonic surgical aspirator in gynecology

      OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA
    29. Boulle, N; Baudin, E; Gicquel, C; Logie, A; Bertherat, J; Penfornis, A; Bertagna, X; Luton, JP; Schlumberger, M; Le Bouc, Y
      Evaluation of plasma insulin-like growth factor binding protein-2 as a marker for adrenocortical tumors

      EUROPEAN JOURNAL OF ENDOCRINOLOGY
    30. Royce, ME; Hoff, PM; Dumas, P; Lassere, Y; Lee, JJ; Coyle, J; Ducharme, MP; De Jager, R; Pazdur, R
      Phase I and pharmacokinetic study of exatecan mesylate (DX-8951f): A novelcamptothecin analog

      JOURNAL OF CLINICAL ONCOLOGY
    31. Schilder, RJ; Gallo, JM; Millenson, MM; Bookman, MA; Weiner, LM; Rogatko, A; Rogers, B; Padavic-Shallers, K; Boente, M; Rosenblum, N; Adams, AL; Ciccotto, S; Ozols, RF
      Phase I trial of multiple cycles of high-dose carboplatin, paclitaxel, andtopotecan with peripheral-blood stem-cell support as front-line therapy

      JOURNAL OF CLINICAL ONCOLOGY
    32. Poon, RTP; Fan, ST; Wong, J
      Clinical implications of circulating angiogenic factors in cancer patients

      JOURNAL OF CLINICAL ONCOLOGY
    33. Thomas, CMG; Sweep, CGJ
      Serum tumor markers: past, state of the art, and future

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    34. Bese, T; Nomir, SK
      The importance of serum insulin-like growth factor-I level determination in the follow-up of patients with epithelial ovarian cancer

      EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    35. Fukushi, Y; Sato, S; Yokoyama, Y; Kudo, K; Maruyama, H; Saito, Y
      Detection of numerical aberration in chromosome 17 and c-erbB2 gene amplification in epithelial ovarian cancer using recently established dual color FISH

      EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    36. Ozalp, S; Yalcin, OT; Gulbas, Z; Tanir, HM; Minsin, T
      Effect of cellular DNA content on the prognosis of epithelial ovarian cancers

      GYNECOLOGIC AND OBSTETRIC INVESTIGATION
    37. Genazzani, AR; Gadducci, A; Gambacciani, M
      Controversial issues in climacteric medicine II - Hormone replacement therapy and cancer

      MATURITAS
    38. La Vecchia, C; Brinton, LA; McTiernan, A
      Menopause, hormone replacement therapy and cancer

      MATURITAS
    39. Sheng, ZJ; Smith, ER; He, JQ; Tuppen, JA; Martin, WD; Dong, FB; Xu, XX
      Chromosomal location of murine Disabled-2 gene and structural comparison with its human ortholog

      GENE
    40. Malik, IA
      Altretamine is an effective palliative therapy of patients with recurrent epithelial ovarian cancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    41. Donahue, A; McCune, JS; Faucette, S; Gillenwater, HH; Kowalski, RJ; Socinski, MA; Lindley, C
      Measured versus estimated glomerular filtration rate in the Calvert equation: influence on carboplatin dosing

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    42. Holm, R; Skovlund, E; Skomedal, H; Florenes, VA; Tanum, G
      Reduced expression of p21(WAF1) is an indicator of malignant behaviour in anal carcinomas

      HISTOPATHOLOGY
    43. Ohtani, K; Sakamoto, H; Kikuchi, A; Nakayama, Y; Idei, T; Igarashi, N; Matukawa, T; Satoh, K
      Follicle-stimulating hormone promotes the growth of human epithelial ovarian cancer cells through the protein kinase C-mediated system

      CANCER LETTERS
    44. Choi, KC; Kang, SK; Nathwani, PS; Cheng, KW; Auersperg, N; Leung, PCK
      Differential expression of activin/inhibin subunit and activin receptor mRNAs in normal and neoplastic ovarian surface epithelium (OSE)

      MOLECULAR AND CELLULAR ENDOCRINOLOGY
    45. Agha-Mohammadi, S; Calne, RY
      Solitary splenic metastasis - Case report and review of the literature

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    46. Yaziji, H; Gown, AM
      Immunohistochemical analysis of gynecologic tumors

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
    47. Hocevar, BA; Smine, A; Xu, XX; Howe, PH
      The adaptor molecule Disabled-2 links the transforming growth factor beta receptors to the Smad pathway

      EMBO JOURNAL
    48. Markman, M; Kennedy, A; Webster, K; Kulp, B; Peterson, G; Belinson, J
      Neurotoxicity associated with a regimen of carboplatin (AUC 5-6) and paclitaxel (175 mg/m(2) over 3 h) employed in the treatment of gynecologic malignancies

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    49. Costa, LA; Fornari, MC; Berardi, VE; Miles, HA; Diez, RA
      In vivo effect of snake phospholipase A(2) (crotoxin plus cardiotoxin) on serum IL-1 alpha, TNF-alpha and IL-1ra level in humans

      IMMUNOLOGY LETTERS
    50. Silberstein, LB; Rosenthal, AN; Coppack, SW; Noonan, K; Jacobs, IJ
      Ascites and a raised serum Ca 125 - confusing combination

      JOURNAL OF THE ROYAL SOCIETY OF MEDICINE
    51. La Vecchia, C; Altieri, A; Franceschi, S; Tavani, A
      Oral contraceptives and cancer - An update

      DRUG SAFETY
    52. Ang, P; Garber, JE
      Genetic susceptibility for breast cancer - Risk assessment and counseling

      SEMINARS IN ONCOLOGY
    53. Gronlund, B; Hogdall, C; Hansen, HH; Engelholm, SA
      Results of reinduction therapy with paclitaxel and carboplatin in recurrent epithelial ovarian cancer

      GYNECOLOGIC ONCOLOGY
    54. Robinson, JB; Singh, D; Bodurka-Bevers, DC; Wharton, JT; Gershenson, DM; Wolf, JK
      Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies

      GYNECOLOGIC ONCOLOGY
    55. Wong, AST; Kim, SO; Leung, PCK; Auersperg, N; Pelech, SL
      Profiling of protein kinases in the neoplastic transformation of human ovarian surface epithelium

      GYNECOLOGIC ONCOLOGY
    56. Simojoki, M; Santala, M; Risteli, J; Kauppila, A
      Carboxyterminal telopeptide of type I collagen (ICTP) in predicting prognosis in epithelial ovarian cancer

      GYNECOLOGIC ONCOLOGY
    57. Makhija, S; Leitao, M; Sabbatini, P; Bellin, N; Almadrones, L; Leon, L; Spriggs, DR; Barakat, R
      Complications associated with intraperitoneal chemotherapy catheters

      GYNECOLOGIC ONCOLOGY
    58. Nicoletto, MO; Artioli, G; Donach, M; Sileni, VC; Monfardini, S; Talamini, R; Veronesi, A; Ferrazzi, E; Tumolo, S; Visona, E; Amichetti, M; Endrizzi, L; Salvagno, L; Prosperi, A; Azzoni, P
      Elderly ovarian cancer: Treatment with mitoxantrone-carboplatin

      GYNECOLOGIC ONCOLOGY
    59. Costa, S; Terzano, P; Bovicelli, A; Martoni, A; Angelelli, B; Santini, D; Ceccarelli, C; Lipponen, P; Erzen, M; Syrjanen, S; Syrjanen, K
      CD44 isoform 6 (CD44v6) is a prognostic indicator of the response to neoadjuvant chemotherapy in cervical carcinoma

      GYNECOLOGIC ONCOLOGY
    60. Burja, AM; Banaigs, B; Abou-Mansour, E; Burgess, JG; Wright, PC
      Marine cyanobacteria - a prolific source of natural products

      TETRAHEDRON
    61. Pham, TH; Hornung, R; Berns, MW; Tadir, Y; Tromberg, BJ
      Monitoring tumor response during photodynamic therapy using near-infrared photon-migration spectroscopy

      PHOTOCHEMISTRY AND PHOTOBIOLOGY
    62. Labbok, MH
      Effects of breastfeeding on the mother

      PEDIATRIC CLINICS OF NORTH AMERICA
    63. Kakolyris, S; Kouroussis, C; Souglakos, J; Mavroudis, D; Agelaki, S; Kalbakis, K; Androulakis, N; Vardakis, N; Vamvakas, L; Georgoulias, V
      A phase I clinical trial of topotecan given every 2 weeks in patients withrefractory solid tumors

      ONCOLOGY
    64. Suzuki, M; Ohwada, M; Saga, Y; Kohno, T; Takei, Y; Sato, I
      Micrometastatic p53-positive cells in the lymph nodes of early stage epithelial ovarian cancer: Prognostic significance

      ONCOLOGY
    65. Key, TJ; Allen, NE; Verkasalo, PK; Banks, E
      Energy balance and cancer: the role of sex hormones

      PROCEEDINGS OF THE NUTRITION SOCIETY
    66. Huang, Y; Friess, H; Kleeff, J; Esposito, I; Zhu, ZW; Liu, SL; Mok, SC; Zimmermann, A; Buchler, MW
      DOC-2/hDab2 expression is up-regulated in primary pancreatic cancer but reduced in metastasis

      LABORATORY INVESTIGATION
    67. Zhou, J; Hsieh, JT
      The inhibitory role of DOC-2/DAB2 in growth factor receptor-mediated signal cascade - DOC-2/DAB2-mediated inhibition of ERK phosphorylation via binding to Grb2

      JOURNAL OF BIOLOGICAL CHEMISTRY
    68. Collie-Duguid, ESR; Johnston, SJ; Boyce, L; Smith, N; Cowieson, A; Cassidy, J; Murray, GI; McLeod, HL
      Thymidine phosphorylase and dihydropyrimidine dehydrogenase protein expression in colorectal cancer

      INTERNATIONAL JOURNAL OF CANCER
    69. Manolitsas, TP; Fowler, JM
      Role of laparoscopy in the management of the adnexal mass and staging of gynecologic cancers

      CLINICAL OBSTETRICS AND GYNECOLOGY
    70. Umemoto, M; Yokoyama, Y; Sato, S; Tsuchida, S; Al-Mulla, F; Saito, Y
      Carbonyl reductase as a significant predictor of survival and lymph node metastasis in epithelial ovarian cancer

      BRITISH JOURNAL OF CANCER
    71. Paradiso, A; Simone, G; De Lena, M; Leone, B; Vallejo, C; Lacava, J; Dellapasqua, S; Daidone, MG; Costa, A
      Expression of apoptosis-related markers and clinical outcome in patients with advanced colorectal cancer

      BRITISH JOURNAL OF CANCER
    72. Tseng, CP; Huang, CH; Tseng, CC; Lin, MH; Hsieh, JT; Tseng, CH
      Induction of disabled-2 gene during megakaryocyte differentiation of K562 cells

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    73. Costa, S; Terzano, P; Santini, D; Ceccarelli, C; Martoni, A; Angelelli, B; Panetta, A; Bovicelli, A; Cristiani, P; Lipponen, P; Erzen, M; Syrjanen, S; Syrjanen, K
      Neoadjuvant chemotherapy in cervical carcinoma - Regulators of cell cycle,apoptosis, and proliferation as determinants of response to therapy and disease outcome

      AJCP. American journal of clinical pathology
    74. Okamura, H; Katabuchi, H
      Detailed morphology of human ovarian surface epithelium focusing on its metaplastic and neoplastic capability

      MOLECULAR, CELLULAR AND DEVELOPMENTAL BIOLOGY OF REPRODUCTION
    75. Canis, M; Botchorishvili, R; Manhes, H; Wattiez, A; Mage, G; Pouly, JL; Bruhat, MA
      Management of adnexal masses: Role and risk of laparoscopy

      SEMINARS IN SURGICAL ONCOLOGY
    76. Laframboise, S; Chapman, W; McLaughlin, J; Andrulis, IL
      p53 Mutations in epithelial ovarian cancers: Possible role in predicting chemoresistance

      CANCER JOURNAL
    77. Bienvenu, J; Monneret, G; Fabien, N; Revillard, JP
      The clinical usefulness of the measurement of cytokines

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    78. Landi, S
      Mammalian class theta GST and differential susceptibility to carcinogens: a review

      MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
    79. Illidge, TM; Brock, S
      Radioimmunotherapy of cancer: Using monoclonal antibodies to target radiotherapy

      CURRENT PHARMACEUTICAL DESIGN
    80. Hata, K; Takebayashi, Y; Akiba, S; Fujiwaki, R; Iida, K; Nakayama, K; Nakayama, S; Fukumoto, M; Miyazaki, K
      Expression of the adrenomedullin gene in epithelial ovarian cancer

      MOLECULAR HUMAN REPRODUCTION
    81. Bischoff, FZ; Simpson, JL
      Heritability and molecular genetic studies of endometriosis

      HUMAN REPRODUCTION UPDATE
    82. van Rijswijk, REN; Vermorken, JB
      Drug therapy for gynaecological cancer in older women

      DRUGS & AGING
    83. Ebert, AD; Wechselberger, C; Martinez-Lacaci, I; Bianco, C; Weitzel, HK; Salomon, DS
      Expression and function of EGF-related peptides and their receptors in gynecological cancer - From basic science to therapy?

      JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH
    84. Vukovic, V; Nicklee, T; Hedley, DW
      Microregional heterogeneity of non-protein thiols in cervical carcinomas assessed by combined use of HPLC and fluorescence image analysis

      CLINICAL CANCER RESEARCH
    85. Wang, LS; Chow, KC; Li, WY; Liu, CC; Wu, YC; Huang, MH
      Clinical significance of serum soluble interleukin 2 receptor-alpha in esophageal squamous cell carcinoma

      CLINICAL CANCER RESEARCH
    86. Gogusev, J; de Joliniere, JB; Telvi, L; Doussau, M; Stojkoski, A; Levardon, M
      Cellular and genetic constitution of human endometriosis tissues

      JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION
    87. Lutgendorf, SK; Anderson, B; Sorosky, JI; Buller, RE; Lubaroff, DM
      Interleukin-6 and use of social support in gynecologic cancer patients

      INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE
    88. Dalton, SO; Johansen, C; Mellemkjaer, L; Sorensen, HT; McLaughlin, JK; Olsen, J; Olsen, JH
      Antidepressant medications and risk for cancer

      EPIDEMIOLOGY
    89. Misset, JL; Bleiberg, H; Sutherland, W; Bekradda, M; Cvitkovic, E
      Oxaliplatin clinical activity: a review

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    90. Matsumoto, Y; Deguchi, M; Ishiko, O; Ogita, S
      Retrospective study of the prognostic factors of remission induction for single-agent chemotherapy with cisplatin in advanced epithelial ovarian cancer

      ONCOLOGY REPORTS
    91. Kuhn, T; Mangold, R; Santjohanser, C; Heuser, T; Hock, S; Zippel, HH; Kreienberg, R
      Complete resection of adnexal masses with endobag extraction: the risk of involuntary tumour rupture

      GYNAECOLOGICAL ENDOSCOPY
    92. La Vecchia, C
      The Pill and cancer

      EUROPEAN JOURNAL OF CANCER PREVENTION
    93. Gwyther, SJ; Nielsen, OS; Judson, IR; van Glabbeke, M; Verweij, J
      Radiologist review versus group peer review of claimed responses in a phase II study on high-dose ifosfamide in advanced soft tissue sarcomas of the adult: a study of the EORTC Soft Tissue and Bone Sarcoma Group

      ANTI-CANCER DRUGS
    94. Nuijen, B; Bouma, M; Manada, C; Jimeno, JM; Schellens, JHM; Bult, A; Beijnen, JH
      Pharmaceutical development of anticancer agents derived from marine sources

      ANTI-CANCER DRUGS
    95. Klip, H; Burger, CW; Kenemans, P; van Leeuwen, FE
      Cancer risk associated with subfertility and ovulation induction: a review

      CANCER CAUSES & CONTROL
    96. Kato, I; Zeleniuch-Jacquotte, A; Toniolo, PG; Akhmedkhanov, A; Koenig, K; Shore, RE
      Psychotropic medication use and risk of hormone-related cancers: the New York University Women's Health Study

      JOURNAL OF PUBLIC HEALTH MEDICINE
    97. Yokoyama, Y; Futagami, M; Fukushi, Y; Sakamoto, T; Higuchi, T; Fujii, S; Sato, S; Takami, H; Saito, Y
      Secondary acute nonlymphocytic leukemia following successful chemotherapy combining cisplatin, doxorubicin, and cyclophosphamide for stage IV epithelial ovarian cancer

      ARCHIVES OF GYNECOLOGY AND OBSTETRICS
    98. Silvestrini, R
      Relevance of DNA-ploidy as a prognostic instrument for solid tumors

      ANNALS OF ONCOLOGY
    99. Kuhajda, FP
      Fatty-acid synthase and human cancer: New perspectives on its role in tumor biology

      NUTRITION
    100. Lichtman, SM; Skirvin, JA
      Pharmacology of antineoplastic agents in older cancer patients

      ONCOLOGY-NEW YORK


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/10/20 alle ore 03:53:11